Searched for
US LENALIDOMIDE
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...08 May, 2026, 10.19 PM IST- Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...02 Apr, 2026, 03.23 PM IST
- Dr Reddy’s gets nod to make generic semaglutide for weight lossDr Reddy's Laboratories is set to launch generic semaglutide, a popular weight loss drug. An expert committee has approved their proposal. ...24 Oct, 2025, 09.19 PM IST
- Biocon shares up 3% after US FDA nod for key cancer drugsBiocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, en...05 Mar, 2025, 09.36 AM IST
- Our key business segments well positioned for growth: CS Muralidharan, Sun PharmaHowever, our outlook on speciality products remains very positive and I expect our existing products will continue to grow. Even in the cur...02 Aug, 2024, 02.59 PM IST
- Natco Pharma launches additional strengths of generic version of Revlimid in USNatco Pharma Ltd on Friday said it has launched additional strengths for its generic lenalidomide capsules used in the treatment of multipl...10 Mar, 2023, 01.26 PM IST
- Sun Pharma gets USFDA nod to market generic medicationIn June 2021, Sun Pharma entered into a settlement with Celgene Corporation (Celgene) to resolve the patent litigation regarding its generi...10 Feb, 2023, 01.15 PM IST
- Dr Reddy's launches generic Revlimid in US market"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...08 Sep, 2022, 01.04 PM IST
- Natco Pharma announces launch of first generic of top selling cancer drug RevlimidRevlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available i...07 Mar, 2022, 10.35 PM IST
- Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...19 Oct, 2021, 12.22 PM IST
- Biocon inks patent litigation settlement pact with CelgeneThe company along with its subsidiaries has entered into a confidential settlement agreement with Celgene Corporation, a wholly-owned subsi...08 Sep, 2021, 01.59 PM IST
- Sun Pharma settles patent litigation with Celgene Corporation for cancer drug RevlimidDrug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revl...22 Jun, 2021, 11.18 AM IST
- Sun Pharma inches up as the company settles a patent litigationPursuant to the terms of the settlement, Celgene will grant Sun Pharma a licensc to Celgene’s patents required to manufacture and sell (sub...22 Jun, 2021, 10.27 AM IST
- Natco Pharma shares hit upper circuit. Here's whyThe Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.24 May, 2021, 11.36 AM IST
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...22 May, 2021, 03.05 PM IST
- Dr Reddy's settles case with Celgene on cancer drugREVLIMID (Lenalidomide) is indicated for treatment for multiple myeloma (cancer).02 Apr, 2019, 03.45 PM IST
- Natco settles patent litigation with Celgene on cancer drugNatco and its US partner Allergan have settled a pending litigation with Celgene regarding generic Lenalidomide capsules used for treatment...23 Dec, 2015, 02.23 PM IST
Load More
